Advertisement

Topics

Companies Related to "Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study" [Most Relevant Company Matches] - Page: 3 RSS

22:20 EDT 26th March 2019 | BioPortfolio

Here are the most relevant search results for "Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study" found in our extensive corporate database of over 50,000 company records.

Showing "Antigonadotropin Leuprolide Alzheimer Disease Drug INvestigation ALADDIN Study" Companies 51–75 of 6,100+

Relevant

Alzheon Inc.

Alzheon, Inc. is committed to developing innovative medicines for patients suffering from Alzheimer’s disease and other neurological and psychiatric disorders. Our lead clinical candidate, ALZ-801, is a first-in-class, oral inhibitor of amyloid aggregation and neurotoxicity - hallmarks of Alzheimer’s disease. ALZ-801 is an optimized, novel prodru...


Nymox Pharmaceutical

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is a biopharmaceutical company specializing in the research and development of therapeutics and diagnostics for the aging population.Nymox has an extensive pipeline of products under development, including therapeutics for enlarged prostate (BPH), a common affliction of males over the age of 50, and for Alzheimer's disease, the most common cause of de...

Gloucester Pharmaceuticals

Gloucester Pharmaceuticals acquires clinical-stage oncology drug candidates and advances them through regulatory approval and commercialization. The Company’s first candidate, ISTODAX® (romidepsin), a novel histone deacetylase (HDAC) inhibitor, is FDA approved for the treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at le...


Banner Alzheimer's Institute

Banner Alzheimer's Institute (BAI) is a treatment and research facility dedicated to helping patients with memory and thinking problems. It offers clinical care for patients; provides education, referral and support services for families and caregivers; and conducts leading-edge brain-imaging, clinical trials, brain imaging and genetics studies. The Institute is devoted to finding effective Alzhei...

BioCarta, Inc

BioCarta was founded in April 2000 to become the leading developer, supplier and distributor of uniquely sourced and characterized reagents and assays for biopharmaceutical and academic research. Proteomics is a promising new field comprising of the study of protein expression and function. A growing number of companies and institutions see proteomics either as a means of enhancing genomic informa...

Proteome Consult

Proteome Consult offers specific expertise concerning the design and management of proteomics studies. Proteome Consult can draw on extensive expertise relating to the investigation of mammalian tissues (including human), plant tissues and cultivated human cell lines. Concluded study designs comprise protein marker discovery, protein inventory and mode of action studies with research foci in drug...

ReGen therapeutics Plc

The principal activity of ReGen Therapeutics Plc is the development and exploration of Colostrinin as a drug for the prophylaxis and treatment of Alzheimer's disease and other neurological disorders. Colostrinin is a proline-rich polypeptide complex isolated from ovine colostrinin. Colostrum is the mammal's first milk after the birth of an offspring.

CNS Network

CNS Network, Inc is dedicated to furthering the knowledge and application of psychiatric medications. We perform trials investigating the efficacy of medications for depression, schizophrenia, bipolar disorder, anxiety and Alzheimer's disease. CNS Network, Inc offers a professional staff including physicians, psychologist, nurses, study coordinators and master level clinicians committed to conduct...

Amen Clinics and Journal of Alzheimer's Disease

Senior Living Residences

Since 1990, Senior Living Residences of Boston, MA has created service-enriched housing and care options for seniors in New England. Fervently adhering to its "Right Values"--Resident Quality of Life, Valued Associates, Integrity and Innovation--SLR is a trusted leader in the communities it serves through innovative programs and services, which exceed industry standards, as well as its high staff ...

Global CEO Initiative on Alzheimer’s Disease and Optum Labs

ProteoTech Inc.

ProteoTech is a privately-held, drug development company that utilizes its amyloid expertise to discover and develop new drugs for treating misfolded protein disorders and amyloid diseases. ProteoTech’s lead small molecule drug, Systebryl™ (PTI-110), will soon be entering a Phase 1/2 proof-of-concept clinical trial in patients with AL (immunoglobulin ...

AGY Therapeutics Incorporated

AGY is an emerging biopharmaceutical company, discovering and developing novel treatments for diseases of the nervous system. AGY scientists have established and utilized a unique mechanism-based approach to identify and characterize new molecules for disease intervention. The intricate molecular networks activated by stress, injury, infection, degeneration and toxins offer a unique basis for sele...

Merz Pharmaceuticals GmbH and DiaGenic ASA

Merz Pharmaceuticals researches, develops, produces and distributes innovative pharmaceutical products in the areas of neurology and psychiatry as well as in aesthetic dermatology and metabolism. In the area of Alzheimer's research, Merz Pharmaceuticals has achieved a leading position with the first active ingredient worldwide for the treatment of moderate to severe Alzheimer's disease. The co...

Satori Pharmaceuticals Incorporated

Satori Pharmaceuticals is committed to the development of disease modifying therapies for Alzheimer's disease through innovative approaches that selectively target the key neurotoxic mediators and pathways of this debilitating neurodegenerative disorder.

Federation of american societes for Expermental biology

Founded in 1912 by three societies, FASEB has consistently provided educational meetings and publications to disseminate biological research results. The then six Member Societies met in 1989 to alter its focus and to reaffirm its mission. The Federation has since experienced significant growth, and is now composed of the following Member Societies:The American Physiological Society American So...

Avid Radiopharmaceuticals, Inc.

Avid Radiopharmaceuticals is a leader in the development of molecular imaging products with the potential for earlier and more effective detection, diagnosis and monitoring of major chronic human diseases. Based in Philadelphia, PA, the company’s lead program is a molecular imaging agent for amyloid plaque that could lead to earlier detection and bett...

Zen-Bio, Inc

Zen-Bio was created to meet the urgent need of investigators interested in understanding human obesity, diabetes, and cardiovascular disease. While rodent models are useful for deciphering metabolic pathways of energy partitioning, the critical analyses for drug development in humans requires an appropriate in vitro model to study human adipocytes.

Active Pass Pharmaceuticals

Active Pass' mission is to be the industry leader in the discovery and development of small-molecule drugs that target human ABC transporters. A family of 48 structurally-related molecular pumps, ABC transporters are targets for diseases with substantial markets including age-related macular degeneration, lipid disorders, Alzheimer's disease, and type II diabetes. Our competitive advantage derives...

Neuroptix Corporation

Neuroptix is creating and developing an innovative, non-invasive eye test to assist in the early diagnosis of Alzheimer’s Disease. Neuroptix’s goal is to provide clinicians with a quick, predictive, reliable, inexpensive and widely available test, enabling early diagnosis and treatment. The company maintains an active interest in collaboration wi...

GlobalCare Clinical Trials, Ltd

GlobalCare Clinical Trials, Ltd, is the leading global provider of ambulant healthcare services for clinical trials to government agencies and the world’s biopharmaceutical and medical device companies engaged in all phases of product development. GlobalCare provides innovative, GCP-compliant services by conducting selected study visits in the home or...

PharmaLinkFHI, Inc.

PharmaLink provides complete eClinical research services to support and streamline the drug development process. Clinical teams leverage real-time study information to make immediate decisions based on emerging trends and study issues. Our accelerated processes, centralized information management and global reach make it possible to conduct trials of any size or complexity from virtually anywhere....

Adeona Pharmaceuticals, Inc.

Adeona (AMEX: AEN) is a pharmaceutical company developing new medicines for serious central nervous systems diseases. Adeona's primary strategy is to in-license clinical-stage drug candidates that have already demonstrated a certain level of clinical efficacy and develop them to an inflection point in valuation resulting in a significant development and marketing collaboration. Trimesta (estriol) ...

Ceregene

Ceregene, Inc. is a San Diego-based biotechnology company focused on the delivery of neurotrophic (or nervous system growth) factors for the treatment of neurodegenerative and retinal disorders using gene delivery. Ceregene's clinical programs include CERE-110, an AAV2 based vector expressing nerve growth factor currently in a multi-center, controlled Phase 2 study for the treatment of Alzheimer's...

NeuroMedix

NeuroMedix is a pharmaceutical company focused on the development of therapeutic agents for the treatment of degenerative and inflammatory diseases of the central nervous system, such as Alzheimer's disease and multiple sclerosis. Our therapeutic candidates are based on research from a team of leading experts in the field of neuroinflammation.In pre-clinical studies, our candidates have proven to ...


More From BioPortfolio on "Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks